Medicine-Infectious Diseases
Academic Department
Research
administers grant
-
A Precision Medicine Approach to Investigating the Molecular Impact of Age and Neurocognitive Impairment in People Living with HIV (PLWH)
-
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
-
A randomized study to evaluate antibody response to an additional dose of SARS-CoV-2 vaccination with and without immunosuppression reduction in kidney and liver transplant recipients
-
ACTG LOC (A5415 FDG PET/CT Scans)
-
ACTG LOC: PF A5379 - Y3 Protocol co-Chair (1560 G YC257)
-
ACTG LOC: PF A5391 – Y2 Protocol co-Chair (1560)
-
ACTG LOC: PF Chair A5386 - Y3 Protocol co-Chair (1560 G YC266)
-
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections, ACTG LOC: PF A5357 - Y3 Protocol Vice Chair (1560)
-
ARLG Pneumonia Direct Pilot ("Study")
-
Aging with HIV: Novel Biomarkers of Inflammation and Morbidity
-
Aging with HIV: Novel Biomarkers of Inflammation and Morbidity - Administrative Supplement
-
Antibacterial Resistance Leadership Group (ARLG)
-
Bacteria and Host in TB Transmission
-
Bacterial and Host Heterogeneity in TB latency, persistence and progression
-
Cefiderocol in the Treatment of Stenotrophomas Maltophilia Pneumonia
-
Characterization of Non-subtype B HIV-1 Reservoirs and its Association with Longitudinal Clinical Outcomes
-
Characterizing non-direct antiviral functions of bNAbs
-
Dalbavancin as an Option for Treatment of S. aureus Bacteremia (DOTS): A Phase 2b, Multicenter, Randomized, Open-Label, Assessor-Blinded Superiority Study to Compare the Efficacy and Safety of Dalbavancin to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients with Complicated S. aureus Bacteremia
-
Decoding epigenetic scars of smoldering neuroinflammation and CNS complications in people with HIV
-
Defining and then Maximizing the Footprint of CTL Selection on HIV Integration Site Landscapes to Optimize Cure Strategies
-
Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection
-
Defining the mechanism of coma in cerebral malaria
-
Delivery of Addiction Treatment for Medicaid Enrollees with Serious Injection-Related Infections
-
Determining the interplay of MAIT cells and the translocated microbiome in HIV-induced neuroinflammation
-
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment
-
Effects of Medication for Opioid Use Disorder on CNS immune activation and Neurocognition in People Living with HIV
-
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure
-
Enhancing Susceptibility of HIV Reservoirs to CTL Through a Discovery to Translational Approach
-
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)
-
Epigenetic dysregulation of inflammation linked to longitudinal cardiac toxicity in perinatal HIV infection
-
Genetic and functional differences between the long terminal repeat transcriptional promoters of intact HIV-1 subtypes B, C and AG proviruses
-
HIV Prevention Trials Network (HPTN 083 FHI360 - WCM)
-
HIV Prevention Trials Network (HPTN 083 FHI360 - WCM)
-
HIV Prevention Trials Network (HPTN106 FHI360 - WCM)
-
HIV Vaccine Research and Development (INHCC)
-
HOPE - HIV Obstruction by Programmed Epigenetics
-
HOPE in Action Prospective Multicenter, Clinical Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients (RTB-009)
-
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer''s from HIV-Associated Cognitive Dysfunction
-
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer''s from HIV-Associated Cognitive Dysfunction
-
Harnessing single cell epigenome-wide profiling of myeloid cells to compare and contrast Alzheimer''s from HIV-associated cognitive dysfunction
-
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression
-
Identifying the Molecular Target of Two Novel Compounds Active Against Non-replicating Mycobacterium tuberculosis and Delineating the Role of the Putative Target, InhA, in Non-replicating States
-
Immunologic control of HIV-1 through combination bNAbs and biologics
-
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence
-
Impact of Microbial Dysbiosis on MAIT Cell Tissue Repair Program after Acute HIV Infection
-
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria
-
Integrated Care for Hepatitis C: Current Uptake & Impact on Future Treatment
-
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) 018 STRIVE Platform Trial
-
Interrogating complex mycobacterial population structures using single-cell RNA sequencing
-
Intrinsic and non-cell autonomous regulation of the SMC epigenetic clock
-
Investigating Cellular Immunometabolic Mechanisms Underlying HIV-Related Cardiovascular Disease Risk
-
Investigating the Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) for Measures of Cardiovascular Disease Risk and Neurocognitive Impairment in People Living with HIV-1
-
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG)
-
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] - A5391
-
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] - PF CRS 7803
-
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] - PF CRS 7804
-
Measurement of HIV Proviral Reservoir Using Intact Proviral DNA Assay
-
Mechanisms of CTL Resistance in HIV Reservoirs
-
Metabolic determinants of Mtb virulence, vulnerability and variation - Core A
-
Metabolic determinants of Mtb virulence, vulnerability and variation - Core B
-
Metabolic determinants of Mtb virulence, vulnerability and variation - Project 2
-
Metabolic determinants of Mtb virulence, vulnerability and variation - Project 3
-
Moderate to Severe COVID-19 Breakthrough Infections After COVID-19 Vaccination and Predictors in Immunocompromised Renal Transplant Recipients
-
Multiomic approaches to treatment-shortening compound development and target identification
-
Open AI/ML-assisted bacterial permeability platform
-
Oral HPV Research Among Latin Americans Living with HIV (ORAL) - H²
-
Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico
-
Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub)
-
Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)
-
Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Innovative Dosing Schedules of AmBisome for Treatment of Experimental Invasive Pulmonary Aspergillosis: Establishing a Preclinical Foundation for Improved Patient Care and Outcome
-
Point of Care Technologies for Nutrition, Infection, and Cancer for Global Health (PORTENT)
-
Protocol MCA-1031 Agreement with Rockefeller University
-
REACH: Research Enterprise to Advance a Cure for HIV
-
RECOVER-NEURO: A Platform Protocol for Evaluation of Interventions for Cognitive Dysfunction in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
-
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
-
Real world experience on the use of ceftolozane-tazobactam in the treatment of Gram-negative bacteremia - a multicentric experience from the United States
-
Relationship between methamphetamine use, viral reservoir dynamics and clinical progression in treated HIV infection
-
Research Training in Infectious Diseases
-
Role of Translesional Polymerases in Genome Diversification of the Malaria Parasite
-
Screening for Fluoroquinolone-Resistant Viridans Group Streptococci to Individualize Infection Prevention Strategies in Neutropenic Patients
-
Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients
-
Social epigenetics of Alzheimer''s disease and related dementias in Latin American countries
-
TBDR Mediated Cefiderocol Resistance in Psuedomonas
-
Targeting HIV reservoirs in the CNS with CAR/CXCR5 T cells for the long-term remission of HIV.
-
Targeting HIV-specific CAR T cells to the gut for the durable remission of HIV
-
Targeting HIV-specific T cell differentiation programs to enhance post-treatment control of HIV
-
The Transmission Biology of Mycobacterium Tuberculosis
-
The effects of immunosuppression on SARS-CoV-2 persistence, virus genetic diversity and clinical outcomes of COVID-19
-
Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck
-
Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck
-
Transporter function of the Mycobacterium tuberculosis PE/PPE proteins.
-
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)
-
Tri-I Training Program in Metabolomics
-
Understanding Immune Evasion by HIV-1 Repliclones
-
Universal HCV screening in pregnancy: Examining testing uptake and HCV care
-
Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials Unit
-
Weill Cornell Medicine Physician-Scientist Academy